Reuters logo
BRIEF-Seqirus receives FDA approval of afluria quadrivalent for people 5 years of age and older
2017年9月14日 / 下午3点51分 / 2 个月前

BRIEF-Seqirus receives FDA approval of afluria quadrivalent for people 5 years of age and older

Sept 14 (Reuters) - Csl Ltd

* Seqirus receives FDA approval of afluria quadrivalent (influenza vaccine) for people five years of age and older in the U.S.

* Says ‍both afluria quadrivalent (influenza vaccine) and afluria (influenza vaccine), are available in U.S. for 2017-2018 influenza season​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below